Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL356698 | 0.71 | AHR (0.50) | AHRAPEX1CYP3A4TSHRTDP1 | |
| SCHEMBL311663 | 0.64 | AHR (0.44) | AHRAPEX1CYP3A4TSHRTDP1 | |
| SCHEMBL10023270 | 0.64 | AHR (0.44) | AHRAPEX1CYP3A4TSHRTDP1 | |
| SCHEMBL11281295 | 0.58 | AHR (0.58) | AHRAPEX1CYP3A4TSHRGAA | |
| SCHEMBL67808 | 0.58 | ALOX15 (0.46) | AHRCYP3A4TSHRTDP1MAPT | |
| SCHEMBL26724 | 0.58 | AHR (0.39) | AHRAPEX1CYP3A4TSHRTDP1 | |
| SCHEMBL22863435 | 0.58 | AHR (0.41) | AHRCYP3A4TSHRGAAMAPT | |
| SCHEMBL2244271 | 0.58 | PTK2 (0.54) | AHRAPEX1CYP3A4TSHRTDP1 | |
| SCHEMBL733675 | 0.58 | AHR (0.39) | AHRAPEX1CYP3A4TSHRTDP1 | |
| SCHEMBL22863606 | 0.58 | PTK2 (0.54) | CYP3A4TSHRTDP1GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230125359-A1 | COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230125359-A1 | COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND | RAD51, UBE2D3, MDM2 | AHR 720/4885APEX1 79/4885CYP3A4 1668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.